EMA
approval
· 2021-02-26
First oral treatment for spinal muscular atrophy (SMA) recommended for approval
Summary
The European Medicines Agency recommends approval of the first oral treatment for spinal muscular atrophy, marking a significant milestone in SMA management.
Upgrade for the full analysis, importance score, and drug timeline.